TWI666029B - Use of albumin-based compound for producing skin-whitening external preparation - Google Patents
Use of albumin-based compound for producing skin-whitening external preparation Download PDFInfo
- Publication number
- TWI666029B TWI666029B TW106117965A TW106117965A TWI666029B TW I666029 B TWI666029 B TW I666029B TW 106117965 A TW106117965 A TW 106117965A TW 106117965 A TW106117965 A TW 106117965A TW I666029 B TWI666029 B TW I666029B
- Authority
- TW
- Taiwan
- Prior art keywords
- albumin
- based compound
- sulfide
- whitening
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
一種美白化粧料,係包含白蛋白類化合物。白蛋白類化合物係硫原子加成於白蛋白或者白蛋白衍生物的化合物。白蛋白類化合物每1部位具有多個硫原子。白蛋白類化合物之製造方法包含使硫化物與白蛋白或者白蛋白衍生物進行加成反應的步驟。白蛋白類化合物包含於美白化粧料。 A whitening cosmetic containing albumin compounds. Albumin compounds are compounds in which a sulfur atom is added to albumin or an albumin derivative. The albumin-based compound has a plurality of sulfur atoms at each site. The method for producing an albumin-based compound includes a step of performing an addition reaction between sulfide and albumin or an albumin derivative. Albumin compounds are contained in whitening cosmetics.
Description
本發明有關一種美白化粧料、及其所含有的白蛋白類化合物之製造方法。 The invention relates to a whitening cosmetic and a method for producing albumin compounds contained therein.
美白化粧品例如已知一種美白用皮膚外用劑(專利文獻1)。該美白用皮膚外用劑含有含有如下成分來作為有效成分,即,使根據需要實施了酵素交聯處理的蛋白質奈米粒子中,內含麩胱甘肽等黑色素生成抑制劑。 As a whitening cosmetic, for example, a skin external preparation for whitening is known (Patent Document 1). This skin external preparation for whitening contains, as an active ingredient, a melanin production inhibitor such as glutathione in protein nano particles that have been subjected to an enzyme cross-linking treatment as necessary.
此外,已知硫化鈉能夠抑制黑色素的產生而具有美白效果,硫化鈉並被考慮應用到化粧品中。 In addition, sodium sulfide is known to have a whitening effect by suppressing the production of melanin, and sodium sulfide is also considered to be applied to cosmetics.
【專利文獻1】日本特許公開專利公開案2008-247814號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2008-247814
專利文獻1中記載的美白用皮膚外用劑中所含有的有效成分的製備中,如上所述,使用了蛋白質奈米粒子。該蛋白質奈米粒子藉由多步驟來製備。為了獲得有效成分,還需要使蛋白質奈米粒子中內含黑色素生成抑制劑。因此,美白用皮膚外用劑中所含有的有效成分的製備較為煩雜。 In the preparation of the active ingredient contained in the whitening skin external preparation described in Patent Document 1, protein nano particles are used as described above. The protein nanoparticle is prepared in multiple steps. In order to obtain an effective ingredient, a melanin production inhibitor needs to be contained in the protein nano particles. Therefore, the preparation of the active ingredient contained in the skin external preparation for whitening is complicated.
另一方面,若使硫化鈉(Na2S)溶解於溶劑而成為溶液的狀態,則成為硫化氫(H2S),就生理pH而言,其大致一半迅速成為氣體而消失。因此,尋求作為硫原子的載體的有用物質,期望開發一種含有穩定狀態的黑色素產生抑制成分(有效成分)的化粧品。On the other hand, when sodium sulfide (Na 2 S) is dissolved in a solvent to be in a solution state, it becomes hydrogen sulfide (H 2 S), and about half of the physiological pH quickly becomes a gas and disappears. Therefore, a useful substance as a carrier of a sulfur atom is sought, and development of a cosmetic containing a melanin production inhibiting component (active ingredient) in a stable state is desired.
本發明鑒於前述課題,目的在於提供一種有效成分的穩定性優異的美白化粧料。並且,其目的還在於提供一種藉由簡單步驟來製造美白化粧料中所含的有效成分之方法。The present invention has been made in view of the foregoing problems, and an object thereof is to provide a whitening cosmetic having excellent stability of effective ingredients. Furthermore, the object is to provide a method for producing an active ingredient contained in a whitening cosmetic by a simple procedure.
本發明的美白化粧料含有白蛋白類化合物。所述白蛋白類化合物是硫原子加成於白蛋白或者白蛋白衍生物的化合物。就所述白蛋白類化合物而言,每1部位具有多個硫原子。The whitening cosmetic of the present invention contains an albumin-based compound. The albumin-based compound is a compound in which a sulfur atom is added to albumin or an albumin derivative. The albumin-based compound has a plurality of sulfur atoms at each site.
本發明的製造方法係白蛋白類化合物之製造方法。所述白蛋白類化合物包含於所述美白化粧料。本發明的製造方法包含使硫化物與白蛋白或者白蛋白衍生物進行加成反應的步驟。 [發明的效果]The manufacturing method of this invention is a manufacturing method of an albumin type compound. The albumin-based compound is included in the whitening cosmetic. The production method of the present invention includes a step of performing an addition reaction between sulfide and albumin or an albumin derivative. [Effect of the invention]
本發明的美白化粧料不僅具有優異的美白效果,而且有效成分的穩定性及安全性優異,具有適合化粧料的氣味。此外,根據本發明的製造方法,藉由簡單的步驟就能夠製造美白化粧料中含有的有效成分。The whitening cosmetic of the present invention not only has excellent whitening effect, but also has excellent stability and safety of active ingredients, and has an odor suitable for the cosmetic. Moreover, according to the manufacturing method of this invention, the active ingredient contained in a whitening cosmetics can be manufactured with a simple process.
以下,對本發明的實施態樣進行詳細說明。本發明不受以下實施態樣的任何限定,在本發明的目的範圍內,可以適當變更後再進行實施。另外,對於重覆說明的地方,存在適當省略的情況,但並不因此限定發明的要旨。並且,有時在有機化合物名稱後加上「類」,來統稱有機化合物及其衍生物。Hereinafter, embodiments of the present invention will be described in detail. The present invention is not limited in any way by the following embodiments, and can be implemented with appropriate modifications within the scope of the object of the present invention. In addition, the repeated description may be appropriately omitted, but this does not limit the gist of the invention. In addition, "classes" are sometimes added to the names of organic compounds to collectively refer to organic compounds and their derivatives.
<第1實施態樣:白蛋白類化合物及其製造方法> 第1實施態樣涉及白蛋白類化合物及其製造方法。白蛋白類化合物作為賦予抑制黑色素產生效果的有效成分,包含於美白化粧料中。<First embodiment: albumin-based compound and method for producing the same> The first embodiment relates to albumin-based compound and method for producing the same. The albumin-based compound is contained in a whitening cosmetic as an active ingredient that imparts an effect of inhibiting the production of melanin.
如上所述,硫化鈉等硫化物抑制黑色素的產生而具有美白效果,因而作為美白化粧料的有效成分而備受關注。化粧料的製備通常使用溶劑,但在硫化物溶解於溶劑的溶液中,硫化物成為硫化氫。溶液中的硫化氫盡管保持了抑制黑色素產生的能力,但其自身容易消失。硫化氫在生理pH(化粧料的最佳pH)溶液中,其大致一半迅速成為氣體而消失。As described above, sulfides such as sodium sulfide have a whitening effect by suppressing the production of melanin. Therefore, they have attracted attention as effective ingredients for whitening cosmetics. A solvent is usually used in the preparation of cosmetics, but in a solution where the sulfide is dissolved in the solvent, the sulfide becomes hydrogen sulfide. Although the hydrogen sulfide in the solution maintains the ability to suppress melanin production, it easily disappears by itself. Approximately half of the hydrogen sulfide in a physiological pH (optimal pH for cosmetics) solution quickly becomes a gas and disappears.
於是,探討了製備一種穩定狀態的白蛋白類化合物,而不是容易消失的硫化氫,來作為有效成分摻配到美白化粧料。Therefore, it is discussed to prepare a stable state albumin compound instead of hydrogen sulfide which is easy to disappear, and to mix it as an active ingredient into a whitening cosmetic.
白蛋白類化合物係硫原子加成於白蛋白或者白蛋白衍生物的化合物,每1個部位具有多個硫原子。白蛋白類化合物的製造方法包含使硫化物與白蛋白或者白蛋白衍生物進行加成反應的步驟。Albumin-based compounds are compounds in which sulfur atoms are added to albumin or an albumin derivative, and each site has a plurality of sulfur atoms. The method for producing an albumin-based compound includes a step of subjecting a sulfide to an addition reaction of albumin or an albumin derivative.
1.白蛋白或者白蛋白衍生物 白蛋白或者白蛋白衍生物係所謂作為硫原子的載體作用的成分。1. Albumin or albumin derivative Albumin or albumin derivative is a component that functions as a carrier of a sulfur atom.
白蛋白或者白蛋白衍生物的種類沒有特別限制。白蛋白係血清白蛋白及基因重組白蛋白中的任意一種。從容易獲得的方面考慮,白蛋白理想的是使用血清白蛋白。血清白蛋白例如有:人血清白蛋白、牛血清白蛋白或者雞血清白蛋白。從具有更高安全性方面考慮,尤其理想的是人血清白蛋白。並且,基因重組的情況下,也含有二聚體或多聚體化的白蛋白。此外,不僅是白蛋白本身,也可以使用白蛋白經過了化學改性的白蛋白衍生物。白蛋白或者白蛋白衍生物既可以單獨使用一種,也可以組合兩種以上來使用。The type of albumin or albumin derivative is not particularly limited. Albumin is any of serum albumin and genetically modified albumin. From the viewpoint of easy availability, it is desirable to use serum albumin. The serum albumin includes, for example, human serum albumin, bovine serum albumin, or chicken serum albumin. From the viewpoint of higher safety, human serum albumin is particularly desirable. In the case of genetic recombination, dimer or multimerized albumin is also contained. In addition, not only albumin itself, but also albumin derivatives that have been chemically modified with albumin can be used. Albumin or an albumin derivative may be used alone or in combination of two or more.
白蛋白或者白蛋白衍生物的分子量沒有特別限制。例如,血清白蛋白的情況下,理想的是使用66000以上66500以下的血清白蛋白。多聚體化的情況下,粒子大小理想的是100nm左右。The molecular weight of albumin or an albumin derivative is not particularly limited. For example, in the case of serum albumin, it is desirable to use serum albumin of 66,000 to 66500. In the case of multimerization, the particle size is preferably about 100 nm.
2.硫化物 硫化物的種類沒有特別限制。硫化物例如有:由通式:Na2 Sn(通式中,n表示1以上6以下的整數)表示的硫化鈉、硫化丙烯(具體而言,二烯丙硫醚或者二硫(2-丙烯))、或者硫(例如,S8 表示的硫)。從容易獲得的方面考慮,硫化物中理想的是使用硫化鈉。從向白蛋白或者白蛋白衍生物的加成反應良好,並且硫原子容易穩定地加成於白蛋白或者白蛋白衍生物的方面考慮,硫化鈉中理想的是多硫化鈉(上述通式中,n表示2以上6以下的整數的化合物)。從獲得具有更高穩定性及更優異的黑色素產生抑制能力的白蛋白類化合物的方面考慮,多硫化鈉中尤其理想的是Na2 S2 、Na2 S3 或者Na2 S4 。硫化物既可以單獨使用一種,也可以組合兩種以上來使用。2. The type of the sulfide is not particularly limited. Examples of the sulfide include sodium sulfide and propylene sulfide (specifically, diallyl sulfide or disulfide (2-propylene) represented by the general formula: Na 2 Sn (wherein n represents an integer of 1 to 6). )), Or sulfur (for example, sulfur represented by S 8 ). From the viewpoint of easy availability, it is desirable to use sodium sulfide in the sulfide. In terms of good addition reaction to albumin or albumin derivatives, and easy addition of sulfur atoms to albumin or albumin derivatives, sodium sulfide is preferably sodium polysulfide (in the above general formula, n represents a compound having an integer of 2 to 6). From the viewpoint of obtaining an albumin-based compound having higher stability and more excellent melanin production suppressing ability, Na 2 S 2 , Na 2 S 3, or Na 2 S 4 is particularly desirable among sodium polysulfides. The sulfides may be used singly or in combination of two or more kinds.
3.加成反應步驟 白蛋白或者白蛋白衍生物與硫化物的反應是加成反應。白蛋白或者白蛋白衍生物與硫化物之間的反應比(白蛋白或者白蛋白衍生物:硫化物)沒有特別限制,但就莫耳濃度比而言,理想的是0.1:1~0.6:1,更理想的是0.2:1~0.5:1。若相對於硫化物1莫耳濃度,白蛋白或者白蛋白衍生物的物質量為0.1莫耳濃度以上,則可以容易去除未反應的硫化物。若相對於硫化物1莫耳濃度,白蛋白或者白蛋白衍生物的物質量為0.6莫耳濃度以下,則可以獲得穩定性更高及黑色素產生抑制能力更優異的白蛋白類化合物。3. Addition reaction step The reaction of albumin or albumin derivative with sulfide is an addition reaction. The reaction ratio between albumin or albumin derivative and sulfide (albumin or albumin derivative: sulfide) is not particularly limited, but in terms of mole ratio, it is preferably 0.1: 1 to 0.6: 1 , More preferably 0.2: 1 to 0.5: 1. If the amount of albumin or albumin derivative is 0.1 mol or more relative to 1 mol concentration of sulfide, unreacted sulfide can be easily removed. When the amount of albumin or albumin derivative is 0.6 mol or less relative to the 1 mol concentration of the sulfide, an albumin compound having higher stability and more excellent melanin production suppressing ability can be obtained.
使硫化物與白蛋白或者白蛋白衍生物進行的加成反應,例如可以採用對白蛋白或白蛋白衍生物及硫化物進行加熱的方法、或者、對白蛋白或者白蛋白衍生物及硫化物進行振盪的方法。尤其理想的方法是對白蛋白或者白蛋白衍生物及硫化物進行加熱的方法,因為此方法不需要特殊裝置,並能夠更簡易地使之進行反應。The addition reaction of sulfide and albumin or albumin derivative can be performed by, for example, heating the albumin or albumin derivative and sulfide, or shaking the albumin or albumin derivative and sulfide. method. A particularly desirable method is a method of heating albumin or an albumin derivative and a sulfide, because this method does not require special equipment and can make it easier to react.
對白蛋白或者白蛋白衍生物及硫化物進行加熱的方法中,向白蛋白或者白蛋白衍生物中加入硫化物,於pH經過調整的緩衝液中,調整反應溫度及反應時間,來使白蛋白或者白蛋白衍生物與硫化物反應。In the method for heating albumin or an albumin derivative and a sulfide, sulfide is added to the albumin or an albumin derivative, and the reaction temperature and reaction time are adjusted in a pH-adjusted buffer solution to make the albumin or Albumin derivatives react with sulfides.
加熱方法中對緩衝液的種類沒有特別限制,例如有:磷酸緩衝液、托立斯鹽酸緩衝液、酞酸緩衝液、檸檬酸緩衝液、琥珀酸緩衝液或者醋酸緩衝液。從容易促進白蛋白或者白蛋白衍生物與硫化物反應的方面考慮,緩衝液的pH理想的是7.0以上7.8以下,更理想的是7.2以上7.6以下。There is no particular limitation on the type of the buffer solution in the heating method, and examples thereof include a phosphate buffer solution, a Torris buffer solution, a phthalic acid buffer solution, a citric acid buffer solution, a succinic acid buffer solution, or an acetic acid buffer solution. From the viewpoint of easily promoting the reaction between albumin or an albumin derivative and a sulfide, the pH of the buffer solution is preferably 7.0 or more and 7.8 or less, and more preferably 7.2 or more and 7.6 or less.
加熱方法中,白蛋白或者白蛋白衍生物與硫化物的反應溫度理想的是30℃以上50℃以下,更理想的是32℃以上45℃以下。若反應溫度30℃以上,則容易促進白蛋白或者白蛋白衍生物與硫化物的反應。若反應溫度為50℃以下,白蛋白或者白蛋白衍生物則不會有發生降解或凝集等變性的可能。In the heating method, the reaction temperature of albumin or an albumin derivative and a sulfide is preferably 30 ° C or higher and 50 ° C or lower, and more preferably 32 ° C or higher and 45 ° C or lower. When the reaction temperature is 30 ° C or higher, the reaction between albumin or an albumin derivative and a sulfide is easily promoted. If the reaction temperature is 50 ° C or lower, there is no possibility that the albumin or the albumin derivative is degraded such as degradation or aggregation.
加熱方法中,從容易促進白蛋白或者白蛋白衍生物與硫化物之間的反應的方面考慮,白蛋白或者白蛋白衍生物與硫化物的反應時間理想的是4小時以上10小時以下,更理想的是5小時以上8小時以下。In the heating method, the reaction time between the albumin or the albumin derivative and the sulfide is preferably from 4 to 10 hours, and more preferably from the viewpoint of facilitating the reaction between the albumin or the albumin derivative and the sulfide. It is 5 hours or more and 8 hours or less.
使白蛋白或者白蛋白衍生物及硫化物進行振盪的方法中,向白蛋白或者白蛋白衍生物中加入硫化物,於pH經過了調整的緩衝液中,調整振盪速度及反應時間,來使白蛋白或者白蛋白衍生物與硫化物進行反應。In the method of oscillating albumin or an albumin derivative and a sulfide, sulfide is added to the albumin or an albumin derivative, and the pH is adjusted in a buffer solution whose pH is adjusted to adjust the oscillation speed and reaction time. The protein or albumin derivative reacts with the sulfide.
振盪方法中對緩衝液的種類沒有特別限制,可以使用上述加熱方法中舉例示出的緩衝液。與上述加熱方法同樣地,緩衝液的pH理想的也是7.0以上7.8以下,更理想的也是7.2以上7.6以下。The type of the buffer is not particularly limited in the shaking method, and the buffers exemplified in the heating method described above can be used. Similarly to the heating method described above, the pH of the buffer solution is preferably 7.0 or more and 7.8 or less, and more preferably 7.2 or more and 7.6 or less.
振盪方法中,白蛋白或者白蛋白衍生物及硫化物的振盪速度只要能夠促進白蛋白或者白蛋白衍生物與硫化物反應即可,沒有特別制限,理想的是調整為30次/分左右以上180次/分左右以下。In the shaking method, the shaking speed of albumin or the albumin derivative and the sulfide is not limited as long as it can promote the reaction between the albumin or the albumin derivative and the sulfide, and is preferably adjusted to about 30 times per minute or more 180 Times per minute or less.
振盪方法中,從容易促進白蛋白或者白蛋白衍生物與硫化物反應的方面考慮,白蛋白或者白蛋白衍生物與硫化物的反應時間理想的是4小時以上10小時以下,更理想的是5小時以上8小時以下。In the shaking method, the reaction time of the albumin or albumin derivative with the sulfide is preferably 4 hours or more and 10 hours or less, and more preferably 5 in terms of facilitating the reaction between the albumin or the albumin derivative and the sulfide. More than 8 hours and less than 8 hours.
此外,白蛋白或者白蛋白衍生物及硫化物的振盪例如可以使用普通的振盪機,由此,只要適當地進行調整,例如使其為上述的振盪速度即可。In addition, the albumin, albumin derivative, and sulfide can be oscillated using, for example, a general oscillator, and as long as it is appropriately adjusted, for example, the above-mentioned oscillation speed may be used.
藉由上述的加熱方法或者振盪方法,能夠使硫化物與白蛋白或者白蛋白衍生物進行加成反應,而例如在氧化劑(具體而言,一氧化氮或者過氧化氫)或者金屬離子的存在下,使硫化物與白蛋白或者白蛋白衍生物進行加成反應,則能夠促進加成反應,並提高反應效率。By the above-mentioned heating method or shaking method, an sulfide can be subjected to an addition reaction with albumin or an albumin derivative, for example, in the presence of an oxidant (specifically, nitric oxide or hydrogen peroxide) or a metal ion When the sulfide is subjected to an addition reaction with albumin or an albumin derivative, the addition reaction can be promoted and the reaction efficiency can be improved.
特別理想的是在金屬離子的存在下進行加成反應,因為其能更促進加成反應,進一步提高反應效率,並容易獲得硫原子充分得以加成的白蛋白類化合物。關於由於金屬離子的存在使得反應效率得以提高的具體情況還不太清楚,可以認為是由於金屬離子吸引了硫化物中的硫原子,從而促進硫原子向白蛋白或者白蛋白衍生物的加成。金屬離子既可以單獨使用一種,也可以組合兩種以上來使用。金屬離子中,從效果更顯著,方便處理的方面考慮,理想的是二價金屬離子。二價金屬離子例如有Fe2 + 、Mg2 + 、Ca2 + 或者Cu2 + 。It is particularly desirable to perform the addition reaction in the presence of metal ions, because it can further promote the addition reaction, further improve the reaction efficiency, and easily obtain albumin compounds with sufficient sulfur atoms to be added. The specific situation that the reaction efficiency is improved due to the presence of metal ions is not clear. It can be considered that the metal ions attracted sulfur atoms in the sulfide, thereby promoting the addition of sulfur atoms to albumin or albumin derivatives. The metal ions may be used singly or in combination of two or more kinds. Among the metal ions, divalent metal ions are desirable in terms of more significant effects and convenient handling. Examples of the divalent metal ion include Fe 2 + , Mg 2 + , Ca 2 +, or Cu 2 + .
在金屬離子的存在下進行加成反應的情況下,就金屬離子與硫化物的比例(金屬離子:硫化物)而言,莫耳濃度比理想的是0.2:1~2:1,更理想的是0.5:1~1.5:1。若相對於硫化物1莫耳濃度,金屬離子的物質量為0.2莫耳濃度以上,則能夠充分發揮提高反應效率的效果。若相對於硫化物1莫耳濃度,金屬離子的物質量為2莫耳濃度以下,則不會由於過剩的金屬離子產生代表性的芬頓反應等致使的氧化反應阻礙加成反應。When the addition reaction is performed in the presence of metal ions, the molar ratio is preferably 0.2: 1 to 2: 1 in terms of the ratio of metal ions to sulfide (metal ion: sulfide), and more preferably It is 0.5: 1 to 1.5: 1. The effect of improving the reaction efficiency can be fully exhibited if the substance mass of the metal ion is 0.2 Molar concentration or more with respect to the 1 mol concentration of the sulfide. When the amount of metal ions is 2 mol or less relative to the 1 mol concentration of sulfide, the addition reaction will not be hindered by the oxidation reaction caused by the excessive metal ions, such as the typical Fenton reaction.
此外,在金屬離子的存在下進行加成反應時,例如可以使用溫泉水。溫泉水一般含有多種如上述那樣的二價金屬離子。因此,根據所含金屬離子種類來適當選擇溫泉水,例如理想的是,調整溫泉水相對於硫化物的使用比例,使得金屬離子與硫化物的比例達到上述的莫耳濃度比範圍。即,根據所含金屬離子種類來適當選擇溫泉水,將硫化物與金屬離子的比例考慮在內来決定溫泉水相對於硫化物的使用比例後,將pH經過了調整的緩衝液與溫泉水混合。該混合液中,向白蛋白或者白蛋白衍生物加入硫化物,由此,在金屬離子的存在下,能夠使硫化物與白蛋白或者白蛋白衍生物進行加成反應。When the addition reaction is performed in the presence of metal ions, for example, hot spring water can be used. Hot spring water generally contains a plurality of divalent metal ions as described above. Therefore, the hot spring water is appropriately selected according to the type of metal ions contained. For example, it is desirable to adjust the use ratio of the hot spring water to the sulfide so that the ratio of the metal ion to the sulfide reaches the above-mentioned molar ratio range. That is, the hot spring water is appropriately selected according to the type of metal ions contained, and the ratio of sulfide to metal ions is taken into consideration to determine the ratio of use of the hot spring water to the sulfide, and then the buffer solution with adjusted pH is mixed with the hot spring water . By adding a sulfide to albumin or an albumin derivative in this mixed solution, the sulfide can be subjected to an addition reaction with albumin or an albumin derivative in the presence of a metal ion.
4.其他步驟 確認白蛋白或者白蛋白衍生物與硫化物的反應結束後,藉由對凝膠進行過濾(例如,藉由使用凝膠過濾管柱層析法),去除未反應的硫化物,從而能夠提純得到目標白蛋白類化合物。4. After confirming the completion of the reaction between albumin or albumin derivative and sulfide in other steps, the gel can be filtered (for example, by using gel filtration column chromatography) to remove unreacted sulfide, thereby enabling Purification to obtain the target albumin compounds.
5.白蛋白類化合物 白蛋白類化合物是硫原子加成於白蛋白或者白蛋白衍生物的化合物,每1個部位具有多個硫原子。5. Albumin-based compounds Albumin-based compounds are compounds in which sulfur atoms are added to albumin or albumin derivatives, and each site has multiple sulfur atoms.
就白蛋白或者白蛋白衍生物而言,原本在其自身具有源自半胱胺酸的SH基團,且半胱胺酸的SH基團被氧化的情況下,藉由S-S鍵共同鍵合而成為半胱胺酸加成物。然而,僅靠只具有SH基團的白蛋白或半胱胺酸加成白蛋白及其衍生物,卻不發揮黑色素產生抑制作用。因此,即使摻配這樣的白蛋白或者白蛋白衍生物,也不能獲得美白效果優異的美白化粧料。In the case of albumin or an albumin derivative, it originally had an SH group derived from cysteine and the SH group of cysteine was oxidized. It becomes a cysteine adduct. However, albumin or cysteine-addition albumin and its derivatives having only SH groups do not exert melanin production inhibitory effects. Therefore, even if such albumin or an albumin derivative is blended, a whitening cosmetic having excellent whitening effect cannot be obtained.
白蛋白類化合物是白蛋白或者白蛋白衍生物中的SH基團及S-S鍵合中,硫原子進一步加成於硫原子,而形成有例如SSH基團、SSSH基團、S-S-S鍵等的化合物。具體情況還不太清楚,但在白蛋白或者白蛋白衍生物中,當在硫原子如此加成於硫原子時,多個硫原子由載體擔載,從而發揮白蛋白或者白蛋白衍生物中沒有的黑色素產生抑制作用。並且,硫原子上進一步加成有硫原子(以下,也稱為多硫加成)的白蛋白類化合物與硫化物不同,生理pH也保持穩定的狀態。An albumin-based compound is a compound in which a sulfur atom is further added to a sulfur atom in an SH group and an S-S bond in albumin or an albumin derivative, and a compound such as an SSH group, an SSSH group, or an S-S-S bond is formed. The specific situation is not clear, but in albumin or albumin derivatives, when the sulfur atom is added to the sulfur atom in this way, multiple sulfur atoms are supported by the carrier, so that there is no effect in albumin or albumin derivatives. Melanin produces an inhibitory effect. In addition, unlike sulfur compounds, albumin compounds having sulfur atoms (hereinafter, also referred to as polysulfide additions) further added to sulfur atoms have physiological pHs that remain stable.
白蛋白類化合物理想的是每1部位具有2個以上6個以下硫原子,更理想的是每1部位具有2個以上4個以下的硫原子。若硫原子沒有加成於白蛋白或者白蛋白衍生物,白蛋白類化合物中,每1部位只存在1個硫原子,則不會如上述那樣具有黑色素產生抑制作用。白蛋白類化合物在每1部位具有6個以下硫原子的情況下,幾乎不會發生硫原子的轉移反應,而被賦予充分的黑色素產生抑制作用,因此白蛋白類化合物容易適用於美白化粧料。並且,關於白蛋白類化合物中硫原子的轉移反應有無的具體情況還不太清楚,可以認為是由於白蛋白類化合物所在環境(溫度、濕度等)引起的。因此,白蛋白類化合物的1部位中的硫原子的數量理想的是上述那樣的6個以下,但並不侷限於此。The albumin-based compound preferably has 2 or more and 6 or less sulfur atoms per site, and more preferably has 2 or more and 4 or less sulfur atoms per site. If a sulfur atom is not added to albumin or an albumin derivative, and there is only one sulfur atom at each site in an albumin compound, the melanin production inhibitory effect will not be as described above. When an albumin compound has less than 6 sulfur atoms per site, a sulfur atom transfer reaction hardly occurs, and sufficient melanin is provided to suppress the effect. Therefore, the albumin compound is easily applicable to whitening cosmetics. In addition, it is not clear whether the sulfur atom transfer reaction in the albumin compounds is due to the environment (temperature, humidity, etc.) where the albumin compounds are located. Therefore, the number of sulfur atoms in one part of the albumin-based compound is preferably six or less as described above, but it is not limited thereto.
白蛋白或者白蛋白衍生物中,SH基團或S-S鍵的存在位置及存在數量被確定。然而,在白蛋白類化合物中,多硫加成部位的存在位置及存在數量卻沒有被確定。其具體情況還不太清楚,可以認為多硫加成部位的存在位置及存在數量根據加成反應的反應條件而適當發生變化。並且,也可以認為白蛋白類化合物中多硫加成部位的存在位置相對於白蛋白或者白蛋白衍生物中SH基團或S-S鍵的存在位置發生變化。In albumin or albumin derivatives, the position and number of SH groups or S-S bonds are determined. However, in albumin compounds, the location and number of polysulfide addition sites have not been determined. The specific situation is not clear, and it can be considered that the position and the number of polysulfide addition sites are appropriately changed according to the reaction conditions of the addition reaction. In addition, it is considered that the position of the polysulfide addition site in the albumin-based compound is changed relative to the position of the SH group or the S-S bond in the albumin or the albumin derivative.
白蛋白類化合物中,各多硫加成部位中存在的硫原子的數量在各部位既可以相同,也可以不同。也就是說,例如,白蛋白或者白蛋白衍生物中的各個SH基團上既可以加成相同數量的硫原子,也可以根據各個SH基團加成不同數量的硫原子。In the albumin compounds, the number of sulfur atoms present in each polysulfide addition site may be the same or different at each site. That is, for example, the same number of sulfur atoms can be added to each SH group in albumin or an albumin derivative, and different numbers of sulfur atoms can be added according to each SH group.
白蛋白類化合物中的硫原子(硫烷硫)的檢測例如可以藉由螢光探針來進行。The sulfur atom (sulfane sulfur) in the albumin-based compound can be detected by, for example, a fluorescent probe.
硫烷硫(Sulfane Sulfur)化合物一般是含有夾在S-S* -S、S-S* -S* -S等硫原子中的硫分子的總稱, 硫烷硫的檢測採用硫烷硫檢測用螢光探針。 硫烷硫檢測用螢光探針理想的是,不破壞細胞或組織就能夠檢測硫烷硫的非破壞性螢光探針。這樣的非破壞性硫烷硫檢測用螢光探針例如有SSP2或者SSP4。SSP2及SSP4具有具備親核性官能基的硫柳酸1分子(SSP2)或者2分子(SSP4),並由作為螢光染料的螢光黃構成,其中,硫柳酸具有親核性官能基。在螢光染料的酚式羥基被硫柳酸保護的狀態下,SSP2及SSP4幾乎不發出螢光,但當硫柳酸與硫烷硫反應時,反應物藉由迅速的分子內環化反應,脫離3H-1,2-苯並二硫醇-3-酮,而生成螢光體。因此,基於該螢光體測量螢光強度,藉由與SSP2或者SSP4的螢光強度進行比較,能夠檢測硫烷硫。Sulfane Sulfur compounds are a general term for sulfur molecules that are trapped in sulfur atoms such as SS * -S, SS * -S * -S, etc. The detection of sulfane sulfur uses a fluorescent probe for sulfane sulfur detection. . The fluorescent probe for sulfane sulfur detection is ideally a non-destructive fluorescent probe capable of detecting sulfane sulfur without damaging cells or tissues. Examples of such a non-destructive sulfane sulfur detection fluorescent probe include SSP2 or SSP4. SSP2 and SSP4 have one molecule (SSP2) or two molecules (SSP4) of thiosalic acid having a nucleophilic functional group, and is composed of fluorescent yellow, which is a fluorescent dye, in which thiosalic acid has a nucleophilic functional group. In the state where the phenolic hydroxyl group of the fluorescent dye is protected by thiosalic acid, SSP2 and SSP4 hardly emit fluorescence, but when thiosalic acid reacts with sulfane sulfur, the reactants undergo a rapid intramolecular cyclization reaction, 3H-1,2-benzodithiol-3-one is released to form a phosphor. Therefore, by measuring the fluorescence intensity based on this phosphor, and comparing with the fluorescence intensity of SSP2 or SSP4, sulfane sulfur can be detected.
以上說明了第1實施態樣所涉及的白蛋白類化合物及其製造方法。藉由第1實施態樣所涉及的製造方法而獲得的白蛋白類化合物的黑色素產生抑制效果、穩定性及安全性優異,並具有適合作為化粧料成分的氣味。第1實施態樣所涉及的製造方法藉由簡單的步驟就能夠製造這樣的白蛋白類化合物。The albumin compounds according to the first embodiment and the method for producing the albumin compounds have been described above. The melanin of the albumin-based compound obtained by the production method according to the first embodiment is excellent in suppressing melanin, has stability and safety, and has an odor suitable as a cosmetic ingredient. The production method according to the first embodiment can produce such an albumin compound in a simple step.
<第2實施態樣:美白化粧料> 第2實施態樣涉及美白化粧料。美白化粧料含有白蛋白類化合物。白蛋白類化合物是第1實施態樣所涉及的白蛋白類化合物,其黑色素產生抑制效果、穩定性及安全性優異,並具有適合作為化粧料成分的氣味。<Second embodiment: Whitening cosmetics> The second embodiment relates to whitening cosmetics. Whitening cosmetics contain albumin compounds. The albumin-based compound is an albumin-based compound according to the first embodiment, which has an excellent melanin production suppressing effect, stability, and safety, and has an odor suitable as a cosmetic ingredient.
美白化粧料中含有的白蛋白類化合物既可以使用一種,也可以不同的兩種以上並用。The albumin compounds contained in the whitening cosmetics may be used singly or in combination of two or more different ones.
美白化粧料中的白蛋白類化合物的摻配量可以根據目標美白化粧料的種類(形態)等來進行適當調整,沒有特別限制。例如,相對於美白化粧料100質量份,按固體成分換算,白蛋白類化合物的摻配量理想的是0.1質量份以上20質量份以下,更理想的是0.12質量份以上0.3質量份以下。白蛋白類化合物的摻配量為0.133質量份以上的情況下,更能夠充分發揮白蛋白類化合物的美白效果。The blending amount of the albumin-based compound in the whitening cosmetic can be appropriately adjusted according to the type (morphology) of the target whitening cosmetic, and is not particularly limited. For example, with respect to 100 parts by mass of the whitening cosmetic material, the blending amount of the albumin-based compound is preferably 0.1 to 20 parts by mass, and more preferably 0.12 to 0.3 parts by mass, in terms of solid content. When the compounding amount of the albumin-based compound is 0.133 parts by mass or more, the whitening effect of the albumin-based compound can be fully exerted.
美白化粧料中除了摻配白蛋白類化合物以外,例如可以適當地摻配通常用於化粧料的添加劑。添加劑例如有:油脂、界面活性劑、保濕劑、美白劑、pH調整劑、增粘劑、防腐劑、抗氧化劑、紫外光吸收劑、顏料、清潔劑、乳化劑、賦形劑或者香料。In addition to blending albumin-based compounds in the whitening cosmetic, for example, additives commonly used in cosmetics can be appropriately blended. Examples of the additives include fats and oils, surfactants, humectants, whitening agents, pH adjusters, tackifiers, preservatives, antioxidants, ultraviolet light absorbers, pigments, detergents, emulsifiers, excipients, or fragrances.
油脂例如有:植物性油脂(具體而言,流動石蠟、石蠟、鯨蠟醇、酪梨油、橄欖油、荷荷芭油或者椰子油)、動物性油脂(具體而言,牛脂、豬脂、馬脂、龜油、貂油、鴨子尾脂腺油(Perselin oil)或者鯊烷)、或者合成油脂(具體而言,甲基聚矽氧烷、二十二醇、辛癸酸甘油酯、三辛酸甘油酯、甘油三異棕櫚酸酯或者聚矽氧油)。Examples of fats and oils include vegetable fats (specifically, mobile paraffin, paraffin, cetyl alcohol, avocado oil, olive oil, jojoba oil, or coconut oil), animal fats (specifically, tallow, lard, Horse fat, turtle oil, mink oil, duck oil (Perselin oil or squalane), or synthetic fats (specifically, methyl polysiloxane, eicosanediol, caprylic acid glyceride, Caprylic acid glyceride, glycerol triisopalmitate or silicone oil).
界面活性劑例如有:陰離子性界面活性劑(具體而言,月桂硫酸鈉、月桂基硫酸三乙醇胺或者月桂酸二乙醇醯胺)、陽離子性界面活性劑(具體而言,硬脂氯化三甲基銨、鯨蠟基氯化三甲基銨或者氯化烷基二甲基芐基銨)、或者非離子性界面活性劑(具體而言,甘油單硬脂酸酯、去水山梨醇單硬脂酸酯、聚氧乙烯(20)去水山梨醇單硬脂酸酯、聚氧乙烯硬化篦蔴油、蔗糖酯、或者脂肪醯胺)。Examples of the surfactant include anionic surfactants (specifically, sodium lauryl sulfate, triethanolamine lauryl sulfate or diethanolammonium laurate), and cationic surfactants (specifically, trimethyl stearate chloride). Ammonium, cetyltrimethylammonium chloride or alkyldimethylbenzylammonium chloride), or non-ionic surfactants (specifically, glycerol monostearate, sorbitan monohard Fatty acid esters, polyoxyethylene (20) sorbitan monostearate, polyoxyethylene hardened ramie oil, sucrose esters, or fatty amines).
保濕劑例如有:合成保濕劑(具體而言,甘油、丙二醇、1,3-丁二醇、氮五圜酮羧酸蘇打或者泛硫醇-S-磺酸鹽)、或者天然保濕劑(具體而言,玻尿酸、膠原蛋白、彈性蛋白、胎盤萃取液、蜂王漿、微生物發酵液、幾丁質、聚葡萄胺糖或者果膠)。Examples of the humectants include synthetic humectants (specifically, glycerin, propylene glycol, 1,3-butanediol, pentafluorenone carboxylic acid soda or panthenol-S-sulfonate), or natural humectants (specifically In terms of hyaluronic acid, collagen, elastin, placenta extract, royal jelly, microbial fermentation broth, chitin, polyglucosamine, or pectin).
美白劑例如示出了白蛋白類化合物以外的化合物,例如有:麴酸、抗壞血酸或者胎盤萃取液。Examples of the whitening agent include compounds other than albumin-based compounds, such as osmic acid, ascorbic acid, or placenta extract.
pH調整劑例如有:檸檬酸或者檸檬酸鈉。Examples of the pH adjusting agent include citric acid or sodium citrate.
增粘劑例如有:羧甲纖維素、羥甲織維素、羥乙基纖維素、聚羧乙烯、聚乙烯醇、黃蓍膠、褐藻酸鈉或者紅藻膠(即卡拉膠,Carrageenan)。Tackifiers include, for example, carboxymethylcellulose, oxymetavin, hydroxyethylcellulose, polycarboxyvinyl, polyvinyl alcohol, tragacanth, sodium alginate, or red algal gum (ie, carrageenan).
防腐劑例如有:對羥基苯甲酸酯(具體而言,對羥基苯甲酸甲酯、對羥基苯甲酸乙酯、對羥基苯甲酸丙酯、或者對羥基苯甲酸丁酯)、2-苯氧乙醇、乙醇或者去氫乙酸。Examples of the preservative include parabens (specifically, methyl parabens, ethyl parabens, propyl parabens, or butyl parabens), 2-phenoxy Ethanol, ethanol or dehydroacetic acid.
抗氧化劑例如有:維生素E、二丁基羥基甲苯(BHT)或者丁基羥基茴香醚(BHA)。Examples of the antioxidant include vitamin E, dibutylhydroxytoluene (BHT), or butylhydroxyanisole (BHA).
紫外光吸收劑例如有:4-咪唑丙烯酸、4-咪唑丙烯酸乙酯、羥苯甲酮、柳酸辛酯、二羥苯基苯基酮、對氨基苯甲酸、對二甲氨基苯甲酸辛酯(Octyl dimethyl p-amino benzoic acid)或者桂皮酸鹽(Octyl methoxycinnamate)。Examples of the ultraviolet light absorber include 4-imidazole acrylic acid, 4-imidazole ethyl acrylate, hydroxybenzophenone, octyl salicylate, dihydroxyphenylphenyl ketone, p-aminobenzoic acid, and octyl p-dimethylaminobenzoate ( Octyl dimethyl p-amino benzoic acid) or octyl methoxycinnamate.
顏料例如有:紅鐵粉、氧化鐵黃、黑氧化鐵、氧化鈦、耐綸粉末、絹雲母、雲母或者滑石。Examples of the pigment include red iron powder, iron oxide yellow, black iron oxide, titanium oxide, nylon powder, sericite, mica, or talc.
清潔劑例如有月桂硫酸鈉。The cleaning agent is, for example, sodium lauryl sulfate.
乳化劑例如有大豆卵磷脂油。An emulsifier is, for example, soybean lecithin oil.
賦形劑例如有硫酸鈉。An excipient is, for example, sodium sulfate.
添加劑的摻配量可以根據目標美白化粧料的種類(形態)等來進行適當調整,只要不妨礙白蛋白類化合物的效果,沒有特別限制。The blending amount of the additives can be appropriately adjusted according to the type (morphology) of the target whitening cosmetic, and is not particularly limited as long as it does not hinder the effect of the albumin-based compound.
美白化粧料的製備方法沒有特別限制,可以採用普通化粧料的製備方法,例如,根據後述的形態適當地決定即可。The method for preparing the whitening cosmetic is not particularly limited, and a method for preparing an ordinary cosmetic may be adopted, and for example, it may be appropriately determined in accordance with the form described later.
美白化粧料的形態沒有特別限制。考慮到美白化粧料優異的美白效果,美白化粧料的形態例如有:基礎化粧品(具體而言,乳膏劑、乳液、爽膚水、潔面乳或者面膜)、或者美容化粧品(具體而言,口紅、粉狀粉底或者液體粉底)。The form of the whitening cosmetic is not particularly limited. Considering the excellent whitening effect of whitening cosmetics, the forms of whitening cosmetics are, for example, basic cosmetics (specifically, creams, lotions, toners, cleansers or masks), or beauty cosmetics (specifically, lipstick, powder) Foundation or liquid foundation).
以上說明了第2實施態樣所涉及的美白化粧料。第2實施態樣所涉及的美白化粧料含有白蛋白類化合物作為有效成分,該白蛋白類化合物的黑色素產生抑制效果、穩定性及安全性優異,具有適合於化粧料的氣味。藉由第2實施態樣所涉及的美白化粧料,能夠抑制由於黑色素的累積產生的色斑、雀斑等,改善膚色暗沈,保持美白的肌膚。 [實施例]The whitening cosmetics according to the second embodiment have been described above. The whitening cosmetic according to the second embodiment includes an albumin-based compound as an active ingredient. The albumin-based compound is excellent in melanin production suppressing effect, stability, and safety, and has an odor suitable for the cosmetic. With the whitening cosmetic material according to the second aspect, it is possible to suppress pigmentation, freckles, and the like caused by accumulation of melanin, improve dull skin tone, and maintain whitening skin. [Example]
以下,藉由實施例進一步對本發明進行具體說明。並且,本發明不受實施例範圍的任何限定。Hereinafter, the present invention will be described in more detail through examples. In addition, the present invention is not limited at all by the scope of the examples.
製造例1(白蛋白類化合物的製造) 磷酸緩衝液(pH7.4)中,向脫脂人血清白蛋白(分子量:66,500、20 mg、300μM)加入Na2 S(78μg、1mM),加熱至37℃使之反應7小時,來在人血清白蛋白上加成硫原子。對於加成反應後的生成物,在下述條件下,對凝膠進行過濾來去除未反應的硫化物,從而獲得目標白蛋白類化合物-1(9.5 mg)。 [凝膠過濾的條件] 移動相: 磷酸緩衝液 流速 : 10mL/分 溫度 : 25℃Production Example 1 (Production of albumin compounds) In a phosphate buffer solution (pH 7.4), Na 2 S (78 μg, 1 mM) was added to defatted human serum albumin (molecular weight: 66,500, 20 mg, 300 μM), and heated to 37 It was allowed to react at 7 ° C for 7 hours to add a sulfur atom to human serum albumin. Regarding the product after the addition reaction, the gel was filtered under the following conditions to remove unreacted sulfides, thereby obtaining the target albumin compound-1 (9.5 mg). [Conditions of gel filtration] Mobile phase: Phosphate buffer flow rate: 10 mL / min Temperature: 25 ° C
製造例2~4(白蛋白類化合物的製造) 除了用Na2 S2 (110μg、1mM、製造例2)、Na2 S3 (142μg、1 mM、製造例3)、或者Na2 S4 (174μg、1 mM、製造例4),來代替Na2 S(78μg、1 mM)以外,與白蛋白類化合物-1的製造同樣地,獲得白蛋白類化合物-2(9.4 mg、製造例2)、白蛋白類化合物-3(9.5 mg、製造例3)或者白蛋白類化合物-4(10.5 mg、製造例4)。Production Examples 2 to 4 (Production of albumin-based compounds) Except Na 2 S 2 (110 μg, 1 mM, Production Example 2), Na 2 S 3 (142 μg, 1 mM, Production Example 3), or Na 2 S 4 ( 174 μg, 1 mM, Production Example 4) Instead of Na 2 S (78 μg, 1 mM), in the same manner as in the production of Albumin Compound-1, Albumin Compound-2 (9.4 mg, Production Example 2) was obtained. , Albumin-based compound-3 (9.5 mg, Production Example 3) or albumin-based compound-4 (10.5 mg, Production Example 4).
試驗例1( 硫烷硫的檢測) 藉由螢光探針來檢測硫烷硫(Sulfane Sulfur)。 硫烷硫檢測用螢光探針用的是SSP2(螢光染料:螢光黃)。Test Example 1 (Detane Sulfide Detection) 检测 Sulfane Sulfur was detected by a fluorescent probe. SSP2 (fluorescent dye: fluorescent yellow) was used as the fluorescent probe for sulfane sulfur detection.
使溴化十六烷基三甲銨(1 mM)溶解於磷酸緩衝液(pH7.4),並向該溶液加入白蛋白類化合物-1~4中的任意一種,使得莫耳濃度為20μM,來製備試樣。於室溫(25℃)下,使該試樣與使SSP2(5μM)溶解於二甲亞碸而獲得的螢光指示劑反應10分鐘後,用分光螢光光度計(日本分光株式會社製造、FP-8200)來測量反應物的螢光強度(激勵波長:457nm、螢光波長:490~580nm)。包括SSP2的螢光強度在內的各反應物的螢光強度如下所示。Cetyltrimethylammonium bromide (1 mM) was dissolved in a phosphate buffer solution (pH 7.4), and any one of albumin compounds 1-4 was added to the solution so that the molar concentration was 20 μM. Prepare the sample. This sample was reacted with a fluorescent indicator obtained by dissolving SSP2 (5 μM) in dimethylarsine at room temperature (25 ° C.) for 10 minutes, and then a spectrofluorimeter (manufactured by JASCO Corporation, FP-8200) to measure the fluorescence intensity of the reactants (excitation wavelength: 457nm, fluorescence wavelength: 490-580nm). The fluorescence intensity of each reactant including the fluorescence intensity of SSP2 is shown below.
螢光強度(無單位) SSP2 512 反應物1(白蛋白類化合物-1) 1135 反應物2(白蛋白類化合物-2) 1219 反應物3(白蛋白類化合物-3) 1534 反應物4(白蛋白類化合物-4) 3380Fluorescence intensity (unit-free) SSP2 512 Reactant 1 (albuminoid-1) 1135 Reactant 2 (albuminoid-2) 1219 Reactant 3 (albuminoid-3) 1534 Reactant 4 (white Protein compounds-4) 3380
如上所述,白蛋白類化合物-1~4的試樣藉由與SSP2的反應,螢光強度都大約是SSP2的螢光強度的2~7倍。這樣,確認到白蛋白類化合物-1~4都在分子內具有硫烷硫。因此,可以得知,白蛋白類化合物-1~4都是硫原子加成於人血清白蛋白的化合物,且每1部位具有多個硫原子。並且,可以得知,白蛋白類化合物-1~4都在生理pH下狀態穩定。As described above, the fluorescence intensity of the samples of albumin compounds 1-4 by reaction with SSP2 is about 2-7 times that of SSP2. In this way, it was confirmed that all of the albumin compounds 1-4 had sulfane sulfur in the molecule. Therefore, it can be seen that the albumin compounds 1-4 are all compounds in which sulfur atoms are added to human serum albumin, and each has a plurality of sulfur atoms at each position. In addition, it can be seen that all of the albumin compounds-1 to 4 are stable at physiological pH.
第2試驗例(黑色素產生抑制效果的確認) 2-1.吸光度的測量及光學顯微鏡照片的拍攝 將B16小鼠黑色素瘤細胞播種於24孔板,於Dulbecco'S Modified Eagle'S Medium(以下,稱為DMEM(+)),在37℃、5%CO2 的條件下預培養24小時,使其成為2.5×104 細胞/孔。接著,將預培養的培養基與添加了白蛋白類化合物-2的DMEM(+)(白蛋白類化合物:20μM、酪胺酸:0.4 mM、NH4Cl:10 mM)進行交換,並於37℃、5%CO2 的條件下培養72小時。Second test example (confirmation of melanin production inhibitory effect) 2-1. B16 mouse melanoma cells were seeded in 24-well plates and measured in absorbance and photographed with a light microscope in Dulbecco'S Modified Eagle'S Medium (hereinafter referred to as DMEM (+)). The cells were prepared at 37 ° C and 5% CO 2 . The cells were cultured for 24 hours to make them 2.5 × 10 4 cells / well. Next, the preculture medium was exchanged with DMEM (+) (albuminoid: 20 μM, tyrosine: 0.4 mM, NH4Cl: 10 mM) to which albumin-type compound-2 was added, and the mixture was incubated at 37 ° C for 5 minutes. % CO 2 was cultured for 72 hours.
並且,取代添加了白蛋白類化合物-2的DMEM(+),預備於添加了磷酸緩衝液(pH7.4)的DMEM(+)所培養者、以及於添加了市面銷售的美白化粧水(熊果苷:最終濃度1.10mM、抗壞血酸:591μM)的DMEM(+)所培養者,來作為對照組。In addition, instead of DMEM (+) to which albumin-based compound-2 was added, those cultured in DMEM (+) with phosphate buffer (pH7.4) were prepared, and commercially available whitening lotions (bear Fruit glycosides: those cultured in DMEM (+) with a final concentration of 1.10 mM and ascorbic acid: 591 μM) were used as a control group.
接著,用磷酸緩衝液(pH7.4)對粘於套管的培養後的B16小鼠黑色素瘤細胞進行清洗後,各加入氫氧化鈉水溶液(1N)200μL。在60℃下,將其培養1小時,使培養後的B16小鼠黑色素瘤細胞溶解,並回收細胞溶解液。用分光光度計(Bio-Rad公司製造、模型680μ量杯),測量細胞溶解液於波長405nm的吸光度。其結果如第1圖所示。並且,405nm是黑色素的吸收波長。並且,用單體全備螢光顯微鏡(KEYENCE CORPORATION製造、BZ-X700,以下,稱為螢光顯微鏡),拍攝培養後的B16小鼠黑色素瘤細胞(400倍)。其結果如第2圖所示。Next, the cultured B16 mouse melanoma cells adhered to the cannula were washed with a phosphate buffer solution (pH 7.4), and then 200 μL of an aqueous sodium hydroxide solution (1N) was added. The cultured B16 mouse melanoma cells were cultured at 60 ° C. for 1 hour, and the cell lysate was recovered. The absorbance of the cell lysate at a wavelength of 405 nm was measured using a spectrophotometer (manufactured by Bio-Rad, model 680 μ measuring cup). The results are shown in Figure 1. In addition, 405 nm is the absorption wavelength of melanin. Furthermore, the B16 mouse melanoma cells (400 times) after culture were photographed using a single-unit fluorescence microscope (manufactured by Keyence Corporation, BZ-X700, hereinafter referred to as a fluorescence microscope). The results are shown in Figure 2.
第1圖係繪示於添加了磷酸緩衝液的DMEM(+)所培養的細胞溶解液、及於添加了白蛋白類化合物-2的DMEM(+)所培養的細胞溶解液於波長405nm的吸光度之條形圖。第1圖中,縱軸表示吸光度(無單位),吸光度越小,產生的黑色素就越少。Figure 1 shows the absorbance of cell lysate cultured in DMEM (+) supplemented with phosphate buffer solution and cell lysate cultured in DMEM (+) supplemented with albumin compound-2 at a wavelength of 405 nm. Bar chart. In Figure 1, the vertical axis represents the absorbance (unitless). The smaller the absorbance, the less melanin is produced.
如第1圖所示,白蛋白類化合物-2於波長405nm的吸光度是作為對照組的磷酸緩衝液於波長405nm的吸光度的大約1/2。As shown in FIG. 1, the absorbance of albumin-based compound-2 at a wavelength of 405 nm is approximately 1/2 of the absorbance of a phosphate buffer solution as a control group at a wavelength of 405 nm.
第2圖(a)係於添加了磷酸緩衝液的DMEM(+)培養的B16小鼠黑色素瘤細胞的SEM照片;第2圖(b)係於添加了市面銷售的美白化粧水的DMEM(+)所培養的B16小鼠黑色素瘤細胞的SEM照片;第2圖(c)係於添加了白蛋白類化合物-2的DMEM(+)所培養的B16小鼠黑色素瘤細胞的SEM照片。第2圖的SEM照片中,黑色斑點之處為黑色素的產生部位。Figure 2 (a) is a SEM photograph of B16 mouse melanoma cells cultured in phosphate-buffered DMEM (+) culture; Figure 2 (b) is a DMEM (+) commercially available whitening lotion ) SEM photograph of B16 mouse melanoma cells; Figure 2 (c) is a SEM photograph of B16 mouse melanoma cells cultured in DMEM (+) supplemented with albumin-2. In the SEM photograph of FIG. 2, the black spots are locations where melanin is generated.
如第2圖所示,使用市面銷售的美白化粧水的情況與使用磷酸緩衝液的情況相比,產生的黑色素少。然而,使用白蛋白類化合物-2卻幾乎沒有產生黑色素,與磷酸緩衝液相比較,明顯抑制了黑色素的產生,就連與市面銷售的美白化粧水相比較,也明顯抑制了黑色素的產生。As shown in FIG. 2, when a commercially available whitening lotion is used, less melanin is generated than when a phosphate buffer solution is used. However, the use of albumin-type compound-2 produced almost no melanin. Compared with phosphate buffered liquid phase, it significantly inhibited the production of melanin, and even compared with commercially available whitening lotions, it also significantly inhibited the production of melanin.
因此,根據第1圖及第2圖可以得知,硫原子加成於白蛋白、且每1部位具有多個硫原子的白蛋白類化合物具有非常優異的黑色素產生抑制效果。Therefore, it can be seen from FIG. 1 and FIG. 2 that an albumin compound having sulfur atoms added to albumin and having a plurality of sulfur atoms at each site has a very excellent melanin production suppressing effect.
2-2.黑色素產生量的測定 將B16小鼠黑色素瘤細胞播種於24孔板,藉由DMEM(+),於37℃、5%CO2 的條件下預培養24小時,使其成為2.5×104 細胞/孔。接著,將預培養了的培養基與添加了白蛋白類化合物-1~4中任意一種的DMEM(+)(白蛋白類化合物:20μM、酪胺酸:0.4 mM、NH4 Cl:10 mM)進行交換,並於37℃、5%CO2 的條件下培養72小時。2-2. Measurement of melanin production amount B16 mouse melanoma cells were seeded in a 24-well plate and pre-cultured with DMEM (+) at 37 ° C and 5% CO 2 for 24 hours to make them 2.5 × 10 4 cells / hole. Next, the pre-cultured medium and DMEM (+) (albumin-based compound: 20 μM, tyrosine: 0.4 mM, NH 4 Cl: 10 mM) to which any of the albumin-based compounds 1-4 were added were performed. Exchange and incubate for 72 hours at 37 ° C and 5% CO 2 .
並且,取代添加了白蛋白類化合物的DMEM(+),預備於添加了製造例1~4中使用的脫脂人血清白蛋白的DMEM(+)培養者,來作為對照組。In addition, instead of DMEM (+) to which albumin compounds were added, DMEM (+) cultures to which delipidated human serum albumin used in Production Examples 1 to 4 were prepared were used as a control group.
接著,用磷酸緩衝液(pH7.4)對粘在套管上的培養後的B16小鼠黑色素瘤細胞進行清洗後,分別加入氫氧化鈉水溶液(1N)200μL。使之於60℃下培養1小時,使培養後的B16小鼠黑色素瘤細胞溶解,並回收細胞溶解液。使用上述「2-1.吸光度的測量及光學顯微鏡照片的拍攝」中所使用相同的分光光度計,測量細胞溶解液於波長405nm的吸光度,來計算培養後的B16小鼠黑色素瘤細胞內的黑色素產生量。其結果如第3圖所示。Next, the cultured B16 mouse melanoma cells adhered to the cannula were washed with a phosphate buffer solution (pH 7.4), and then 200 μL of an aqueous sodium hydroxide solution (1N) was added. The cells were cultured at 60 ° C. for 1 hour, the cultured B16 mouse melanoma cells were lysed, and the cell lysate was recovered. Using the same spectrophotometer used in the above "2-1. Measurement of Absorbance and Photographing of Optical Microscopy", the absorbance of the cell lysate at a wavelength of 405 nm was measured to calculate the melanin in the B16 mouse melanoma cells after culture. Generated. The results are shown in Figure 3.
第3圖係繪示各細胞溶解液中培養後的B16小鼠黑色素瘤細胞內的黑色素產生量的條形圖。第3圖中,縱軸表示細胞溶解液(1mL)中的黑色素產生量(mg)。FIG. 3 is a bar graph showing the amount of melanin production in B16 mouse melanoma cells cultured in each cell lysate. In Fig. 3, the vertical axis represents the amount of melanin produced (mg) in the cell lysate (1 mL).
如第3圖所示,白蛋白類化合物-1~4與作為對照組的脫脂人血清白蛋白相比,黑色素產生量都少。由此可以得知,硫原子加成於白蛋白、且每1部位具有多個硫原子的白蛋白類化合物與白蛋白相比較,具有優異的黑色素產生抑制效果。As shown in Fig. 3, the amount of melanin produced by the albumin compounds 1-4 was lower than that of the defatted human serum albumin as a control group. From this, it can be seen that an albumin compound having a sulfur atom added to albumin and having a plurality of sulfur atoms per site has an excellent melanin production suppressing effect compared to albumin.
尤其是使脫脂人血清白蛋白分別與Na2 S2 、Na2 S3 及Na2 S4 進行加成反應後的白蛋白類化合物-2、白蛋白類化合物-3及白蛋白類化合物-4的黑色素產生量非常少。由此可以得知,藉由使硫化物中、尤其是Na2 S2 、Na2 S3 或Na2 S4 之類的多硫化鈉與白蛋白進行加成反應而獲得的白蛋白類化合物具有更優異的黑色素產生抑制效果。In particular, albumin-based compounds-2, albumin-based compounds-3, and albumin-based compounds- 4 are subjected to addition reactions of defatted human serum albumin with Na 2 S 2 , Na 2 S 3 and Na 2 S 4 respectively. The amount of melanin produced is very small. From this, it can be known that the albumin compounds obtained by the addition reaction of sulfide, especially sodium polysulfide such as Na 2 S 2 , Na 2 S 3 or Na 2 S 4 , with albumin have More excellent melanin produces an inhibitory effect.
第3試驗例(蛋白質濃度的測量) 用生理食鹽水對藉由與上述第2試驗例的「2-2.黑色素產生量的測量」相同的方法來培養的B16小鼠黑色素瘤細胞清洗2次以上,從套管上盡可能地吸取水分。向其加入氫氧化鈉200μL後,將細胞萃取物轉移至微管,於60℃下培養2小時。將培養後的上清的蛋白質溶液回收至新的微管,以此作為試樣。Third Test Example (Measurement of Protein Concentration) 黑色 B16 mouse melanoma cells cultured in the same manner as in "2-2. Measurement of Melanin Production Amount" described above in the second test example were washed twice with physiological saline. As above, absorb as much water as possible from the sleeve. After 200 μL of sodium hydroxide was added thereto, the cell extract was transferred to a microtube and cultured at 60 ° C. for 2 hours. The protein solution of the cultured supernatant was recovered into a new microtube and used as a sample.
此外,預備BSA(牛血清白蛋白)標準蛋白質溶液(蛋白質濃度:1 mg/mL、0.5 mg/mL、0.25 mg/mL、或者0.125 mg/mL),來作為標準溶液。In addition, a BSA (bovine serum albumin) standard protein solution (protein concentration: 1 mg / mL, 0.5 mg / mL, 0.25 mg / mL, or 0.125 mg / mL) was prepared as the standard solution.
試驗管中,取各試樣10μL、各標準溶液10μL、或背景溶液10μL,並分別加入蛋白質定量試藥(二喹啉甲酸試藥)100μL均勻攪拌,於37℃下加熱30分鐘。確認驗管內溶液的溫度降低至室溫(25℃)後,使用上述第2試驗例的「2-1.吸光度的測量及光學顯微鏡照片的拍攝」中用的分光光度計來測量吸光度。In the test tube, take 10 μL of each sample, 10 μL of each standard solution, or 10 μL of background solution, and add 100 μL of the protein quantification reagent (diquinolinecarboxylic acid reagent) and stir uniformly, and heat at 37 ° C for 30 minutes. After confirming that the temperature of the solution in the test tube was reduced to room temperature (25 ° C), the absorbance was measured using a spectrophotometer used in "2-1. Measurement of Absorbance and Photographing of Optical Microscope" in the second test example described above.
於波長540nm的背景溶液的吸光度設定為0.00。接著,測量波長540nm中各標準溶液的吸光度,製作標準直線。測量各試樣於波長540nm的吸光度之後,用標準溶液的標準直線,求出各試樣的蛋白質濃度。各試樣的蛋白質濃度如下所示。The absorbance of the background solution at a wavelength of 540 nm was set to 0.00. Next, the absorbance of each standard solution at a wavelength of 540 nm was measured to prepare a standard straight line. After measuring the absorbance of each sample at a wavelength of 540 nm, the protein concentration of each sample was determined using the standard straight line of the standard solution. The protein concentration of each sample is shown below.
蛋白質濃度(mg/mL) 對照組(人血清白蛋白) 0.81 試樣1(白蛋白類化合物-1) 0.84 試樣2(白蛋白類化合物-2) 0.88 試樣3(白蛋白類化合物-3) 0.97 試樣4(白蛋白類化合物-4) 0.95Protein concentration (mg / mL) Control group (human serum albumin) 0.81 Sample 1 (albuminoid-1) 0.84 Sample 2 (albuminoid-2) 0.88 Sample 3 (albuminoid-3) ) 0.97 Sample 4 (Albumin-4) 0.95
第4試驗例(確認金屬離子產生的效果) 4-1. 硫烷硫的檢測 首先,製備測量試樣1a及2a。使脫脂人血清白蛋白(20mg、300μM)溶解於磷酸緩衝液(pH7.4)與氯化鐵(Fe3 + 濃度:1 mM)的混合液,來製備測量試樣1a。使脫脂人血清白蛋白(20mg、300μM)溶解於磷酸緩衝液與氯化銅(Cu2 + 濃度:1 mM)的混合液,來製備測量試樣2a。Fourth test example (confirmation of effect of metal ion generation) 4-1. Detection of sulfane sulfur First, measurement samples 1a and 2a were prepared. Defatted human serum albumin (20 mg, 300 μM) was dissolved in a mixed solution of a phosphate buffer solution (pH 7.4) and ferric chloride (Fe 3 + concentration: 1 mM) to prepare a measurement sample 1 a. Degreased human serum albumin (20mg, 300μM) was dissolved in phosphate buffer and copper (Cu 2 + concentration: 1 mM) of the chloride mixture to prepare the measurement specimen 2a.
接著,製備測量試樣1b及2b。磷酸緩衝液(pH7.4)與氯化鐵(Fe3 + 濃度:1 mM)的混合液中,對脫脂人血清白蛋白(20 mg、300μM)加入Na2 S(78μg、1 mM),並加熱至37℃使其反應7小時,來使硫原子加成於人血清白蛋白。對於加成反應後的生成物,於與製造例1相同的條件對凝膠進行過濾,去除未反應的硫化物,來製備測量試樣1b。除了用磷酸緩衝液與氯化銅(Cu2 + 濃度:1 mM)的混合液來代替磷酸緩衝液(pH7.4)與氯化鐵(Fe3 + 濃度:1 mM)的混合液以外,藉由與製備測量試樣1b同樣的方法來製備測量試樣2b。Next, measurement samples 1b and 2b were prepared. To a mixture of phosphate buffer solution (pH 7.4) and ferric chloride (Fe 3 + concentration: 1 mM), add Na 2 S (78 μg, 1 mM) to defatted human serum albumin (20 mg, 300 μM), and The mixture was heated to 37 ° C for 7 hours to add a sulfur atom to human serum albumin. About the product after the addition reaction, the gel was filtered under the same conditions as in Production Example 1 to remove unreacted sulfides to prepare a measurement sample 1b. Except phosphate buffer and copper chloride: a mixture of (Cu 2 + concentration of 1 mM) is used instead of phosphate buffer (pH7.4) and ferric chloride (Fe 3 + concentration: 1 mM) than a mixture, by The measurement sample 2b is prepared by the same method as that of the measurement sample 1b.
對於測量試樣1a及2a、以及測量試樣1b及2b,藉由與上述試驗例1相同的螢光探針,進行硫烷硫的檢測。The measurement samples 1a and 2a and the measurement samples 1b and 2b were subjected to detection of sulfane sulfur by the same fluorescent probe as in Test Example 1 described above.
即,使測量試樣與SSP2(5μM)溶解於二甲亞碸的螢光指示劑於室溫(25℃)下反應10分鐘後,用分光螢光光度計來測量反應物的螢光強度。其結果如第4圖所示。That is, the reaction between the measurement sample and the fluorescent indicator in which SSP2 (5 μM) was dissolved in dimethylarsine was carried out at room temperature (25 ° C.) for 10 minutes, and then the fluorescence intensity of the reactant was measured with a spectrofluorometer. The results are shown in Figure 4.
第4圖係繪示測量試樣1a及2a、以及測量試樣1b及2b的螢光強度的條形圖。第4圖中,縱軸表示螢光強度(無單位)。Fig. 4 is a bar graph showing the fluorescence intensities of the measurement samples 1a and 2a and the measurement samples 1b and 2b. In Fig. 4, the vertical axis represents the fluorescence intensity (unitless).
如第4圖所示,測量試樣1b的螢光強度高於測量試樣1a的螢光強度,測量試樣2b的螢光強度高於測量試樣2a的螢光強度。由此可以得知,於金屬離子的存在下使人血清白蛋白與硫化鈉反應,促進了硫原子向人血清白蛋白的加成反應。As shown in FIG. 4, the fluorescence intensity of the measurement sample 1b is higher than that of the measurement sample 1a, and the fluorescence intensity of the measurement sample 2b is higher than that of the measurement sample 2a. From this, it can be known that reacting human serum albumin with sodium sulfide in the presence of metal ions promotes the addition reaction of sulfur atoms to human serum albumin.
此外,測量試樣2b的螢光強度與測量試樣2a的螢光強度之差遠遠大於測量試樣1b的螢光強度與測量試樣1a的螢光強度之差。由此可以得知,尤其係使二價Cu2 + 存在比使三價Fe3 + 存在更容易促進硫原子向人血清白蛋白的加成反應。Further, the difference between the fluorescence intensity of the measurement sample 2b and the fluorescence intensity of the measurement sample 2a is much larger than the difference between the fluorescence intensity of the measurement sample 1b and the fluorescence intensity of the measurement sample 1a. It can be that, in particular based divalent abundance ratio Cu 2 + Fe 3 + trivalent much easier to promote the presence of an addition reaction of sulfur atom to a human serum albumin.
4-2.黑色素產生量的測量 使後述的表1及表2所示pH及成分的溫泉水-1~10按66.7質量%的比例混合於磷酸緩衝液(pH7.4)得到的混合溶液中,對脫脂人血清白蛋白(20 mg、300μM)加入Na2 S2 (110μg、1 mM),並加熱至37℃使其反應7小時,來使硫原子加成於人血清白蛋白。對於加成反應後的生成物,於與製造例1相同的條件下,對凝膠進行過濾來去除未反應的硫化物,並獲得白蛋白類化合物-2A~2J(10~18 mg)。並且,表1及表2中,氡以外的各成分的量是每1kg溫泉水的含有量(mg),氡的量是每1kg溫泉水的含有量(×10- 10 Ci)。4-2. The measurement of the amount of melanin produced was performed by mixing hot spring water with a pH and components shown in Tables 1 and 2 described below in a proportion of 66.7% by mass to a mixed solution obtained with a phosphate buffer solution (pH 7.4). Serum albumin (20 mg, 300 μM) was added with Na 2 S 2 (110 μg, 1 mM) and heated to 37 ° C. for 7 hours to add sulfur atoms to human serum albumin. Regarding the product after the addition reaction, the gel was filtered under the same conditions as in Production Example 1 to remove unreacted sulfides, and albumin compounds-2A to 2J (10 to 18 mg) were obtained. Further, Table 1 and Table 2, the amount of each component other than containing radon hot spring water per 1kg (mg), containing the amount of radon hot spring water per 1kg (× 10 - 10 Ci).
【表1】
【表2】
將B16小鼠黑色素瘤細胞播種於24孔板,藉由DMEM(+)於37℃、5%CO2 的條件下預培養24小時,使其為2.5×104 細胞/孔。接著,將預培養了的培養基與添加了白蛋白類化合物-2A~2J中任意一種的DMEM(+)(白蛋白類化合物:20μM、酪胺酸:0.4 mM、NH4 Cl:10 mM)交換,並於37℃、5%CO2 的條件下培養72小時。B16 mouse melanoma cells were seeded in a 24-well plate and pre-cultured with DMEM (+) at 37 ° C. and 5% CO 2 for 24 hours to 2.5 × 10 4 cells / well. Next, the pre-cultured medium was exchanged with DMEM (+) (albumin-based compound: 20 μM, tyrosine: 0.4 mM, NH 4 Cl: 10 mM) to which any of the albumin-based compounds 2A to 2J was added. , And cultured at 37 ° C and 5% CO 2 for 72 hours.
此外,取代添加了白蛋白類化合物-2A~2J的任意一種的DMEM(+),預備於添加了製造例1中用的脫脂人血清白蛋白的DMEM(+)所培養者,來作為對照組。並且,取代添加了白蛋白類化合物-2A~2J中任意一種的DMEM(+),還一起預備於添加了白蛋白類化合物-2(不用溫泉水而製造)的DMEM(+)所培養者。In addition, instead of DMEM (+) to which any of the albumin compounds-2A to 2J was added, those cultured in DMEM (+) to which the defatted human serum albumin used in Production Example 1 was added were prepared as a control group. . In addition, instead of DMEM (+) to which any of the albumin-based compounds-2A to 2J was added, they were also prepared together with those cultured in DMEM (+) to which the albumin-based compound-2 (made without hot spring water) was added.
接著,與上述第2試驗例的「2-2.黑色素產生量的測量」同樣地,回收細胞溶解液,用上述第2試驗例的「2-1.吸光度的測量及光學顯微鏡照片的拍攝」中用的分光光度計,測量細胞溶解液的波長405nm的吸光度,並計算培養後的B16小鼠黑色素瘤細胞內的黑色素產生量。其結果如第5圖所示。Next, the cell lysate was recovered in the same manner as "2-2. Measurement of melanin production amount" in the second test example, and "2-1. Measurement of absorbance and photographing of an optical microscope photograph" were used in the second test example. The spectrophotometer was used to measure the absorbance of the cell lysate at a wavelength of 405 nm, and the amount of melanin produced in the melanoma cells of the B16 mouse after the culture was calculated. The results are shown in Figure 5.
第5圖係繪示各細胞溶解液中培養後的B16小鼠黑色素瘤細胞內的黑色素產生量的條形圖。第5圖中,縱軸表示細胞溶解液(1 mg/mL)中的吸光度(450nm)。FIG. 5 is a bar graph showing the amount of melanin production in B16 mouse melanoma cells cultured in each cell lysate. In Fig. 5, the vertical axis represents the absorbance (450 nm) in the cell lysate (1 mg / mL).
如第5圖所示,即使在白蛋白類化合物-2A~2J中,與作為對照組的脫脂人血清白蛋白相比,顯然不僅白蛋白類化合物-2C~2E及2F~2J的黑色素產生量非常少,而且與不用溫泉水而製造的白蛋白類化合物-2相比,黑色素產生量也非常少。由此可以得知,於含有各種金屬離子的溫泉水的存在下使人血清白蛋白與硫化鈉反應,硫原子更充分地進行加成,獲得黑色素產生抑制效果更優異的白蛋白類化合物。As shown in Fig. 5, even in the albumin-based compounds -2A to 2J, it is clear that not only the albumin-based compounds -2C to 2E and 2F to 2J produce melanin in comparison with the defatted human serum albumin as a control group. It is very small, and the amount of melanin produced is very small compared with the albumin compound-2 produced without using hot spring water. From this, it can be seen that human serum albumin and sodium sulfide are reacted in the presence of hot spring water containing various metal ions, sulfur atoms are more fully added, and albumin compounds having an excellent melanin production inhibitory effect are obtained.
第5試驗例(安全性的確認) 首先,配製摻配有白蛋白類化合物的美白化粧料。使以下白蛋白類化合物以外的各成分按以下摻配量(固體成分換算)進行製備後,加熱至50℃並進行攪拌混合,使其成為均勻的狀態。將混合物冷卻至室溫(25℃),並進一步混合白蛋白類化合物後,獲得乳膏劑A。Fifth Test Example (Confirmation of Safety) First, a whitening cosmetic material containing an albumin compound was prepared. Each component other than the following albumin-based compounds was prepared at the following blending amount (in terms of solid content), and then heated to 50 ° C. with stirring and mixing to make it uniform. After the mixture was cooled to room temperature (25 ° C) and the albumin-based compound was further mixed, cream A was obtained.
成分 摻配量(質量份) 白蛋白類化合物-2 0.133 乳化臘 5 荷荷芭油 15 淨化水 殘餘量 (合計) 100Ingredients blending amount (parts by mass) albumin compounds-2 0.133 emulsified wax 5 jojoba oil 15 净化 purified water residual amount (total) 100
並且,除了摻配白蛋白類化合物-2 D來代替上述的白蛋白類化合物-2以外,藉由與制備乳膏劑A同樣的方法獲得乳膏劑B。並且,除了不摻配上述的白蛋白類化合物-2以外,藉由與制備乳膏劑A相同的方法,獲得對照組的乳膏劑。Furthermore, cream B was obtained by the same method as preparation of cream A, except that albumin-based compound-2 D was blended in place of the above-mentioned albumin-based compound-2. In addition, the cream of the control group was obtained by the same method as that of the cream A except that the above-mentioned albumin-based compound-2 was not blended.
依照經濟協力開發機構所示準則(有關化學物質的試驗的OECD準則)TG439「in vitro皮膚刺激性:重組人表皮試驗法」中記載的方法,基於三維培養皮膚細胞的存活率來評價乳膏劑A、乳膏劑B及對照組的乳膏劑的安全性。其結果如第6圖所示。The cream A was evaluated based on the survival rate of three-dimensionally cultured skin cells in accordance with the method described in the Economic Development Cooperation Agency (OECD guidelines for testing of chemical substances) TG439 "in vitro skin irritation: recombinant human epidermal test". , Cream B and the safety of the control group. The results are shown in Figure 6.
第6圖是繪示各乳膏劑中細胞存活率的條形圖。第6圖中,縱軸表示細胞存活率(%)。並且,細胞存活率超過50%的情況下,判斷為沒有皮膚刺激性。Fig. 6 is a bar graph showing the cell survival rate in each cream. In Fig. 6, the vertical axis represents the cell survival rate (%). When the cell survival rate exceeds 50%, it is determined that there is no skin irritation.
如第6圖所示,乳膏劑A及乳膏劑B與對照組的乳膏劑同樣地,細胞存活率都超過50%。由此可以得知,不用溫泉水而製造的白蛋白類化合物-2及於溫泉水的存在下製造的白蛋白類化合物-2D都沒有皮膚刺激性,且安全性高。As shown in FIG. 6, cream A and cream B had cell survival rates exceeding 50% in the same manner as the cream of the control group. From this, it can be known that neither the albumin-based compound-2 produced without hot spring water nor the albumin-based compound 2D produced in the presence of hot spring water has no skin irritation and high safety.
並且,白蛋白類化合物-2及白蛋白類化合物-2D都不具有硫化氫氣味,因而沒有不適的氣味。因此,摻配有白蛋白類化合物-2的乳膏劑A及摻配有白蛋白類化合物-2D的乳膏劑B都沒有不適的氣味。In addition, neither the albumin-based compound-2 nor the albumin-based compound-2D has a hydrogen sulfide odor, so there is no unpleasant odor. Therefore, neither Cream A doped with Albumin Compound-2 nor Cream B doped with Albumin Compound-2D did not have an unpleasant odor.
第6試驗例(細胞內ROS及NO的測量) 使用螢光試劑CM-H2 DCF-DA、CM-H2 DCF-DA,測量基於細胞內活性氧(ROS)及一氧化氮(NO)的螢光強度。Sixth Test Example (Measurement of intracellular ROS and NO) The fluorescence reagents CM-H 2 DCF-DA and CM-H 2 DCF-DA were used to measure intracellular reactive oxygen species (ROS) and nitric oxide (NO). Fluorescence intensity.
將B16小鼠黑色素瘤細胞播種於96孔板,藉由DMEM(+)於37℃、5%CO2 的條件下預培養24小時,使其為1×104 細胞/孔。B16 mouse melanoma cells were seeded in a 96-well plate, and pre-cultured with DMEM (+) at 37 ° C and 5% CO 2 for 24 hours to 1 × 10 4 cells / well.
向培養基添加螢光試劑CM-H2 DCF-DA直至濃度達到5μM,並於37℃下使其反應30分鐘來將其取入細胞內。反應後,去除上澄液(上清液)後,添加白蛋白類化合物-4。預備進行了同樣操作的培養基,作為添加了磷酸緩衝液(pH7.4)及脫脂人血清白蛋白的樣品,以其作為對照組。對各個樣品照射波長254nm的紫外線10分鐘。然後,照射波長485nm的激磁光,測量波長535nm的螢光強度。Fluorescent reagent CM-H 2 DCF-DA was added to the culture medium until the concentration reached 5 μM, and it was reacted at 37 ° C. for 30 minutes to take it into the cells. After the reaction, the supernatant (supernatant) was removed, and then albumin-based compound-4 was added. The same culture medium was prepared as a sample to which a phosphate buffer (pH 7.4) and defatted human serum albumin were added, and this was used as a control group. Each sample was irradiated with ultraviolet light having a wavelength of 254 nm for 10 minutes. Then, the excitation light having a wavelength of 485 nm was irradiated, and the fluorescence intensity at a wavelength of 535 nm was measured.
並且,向培養基添加螢光試劑DAF-FM-DA直至濃度達到10μM,並於37℃下反應30分鐘,將其取入細胞內,來作為一氧化氮(NO)測量用的懸濁液樣品。反應後,將培養基替代為基白蛋白類化合物-4溶液。同樣的培養基中,預備用磷酸緩衝液(pH7.4)及脫脂人血清白蛋白溶液替代的樣品,來作為對照組。向這些樣品照射波長254nm的紫外線10分鐘。對所得的樣品照射波長485nm的激磁光,來測量波長535nm的螢光強度。Then, the fluorescent reagent DAF-FM-DA was added to the culture medium until the concentration reached 10 μM, and the reaction was carried out at 37 ° C. for 30 minutes, and the cells were taken as a suspension sample for nitric oxide (NO) measurement. After the reaction, the medium was replaced with a base albumin-based compound-4 solution. In the same medium, a sample substituted with a phosphate buffer solution (pH 7.4) and a defatted human serum albumin solution was prepared as a control group. These samples were irradiated with ultraviolet light having a wavelength of 254 nm for 10 minutes. The obtained sample was irradiated with excitation light having a wavelength of 485 nm to measure the fluorescence intensity at a wavelength of 535 nm.
第7圖(a)及第7圖(b)分別係繪示起因於細胞內活性氧及一氧化氮的平均螢光強度的條形圖。螢光強度越少,表示細胞內含有的活性氧(ROS)及一氧化氮(NO)越少。Figures 7 (a) and 7 (b) are bar graphs showing the average fluorescence intensity due to intracellular reactive oxygen species and nitric oxide, respectively. The lower the fluorescence intensity, the less active oxygen (ROS) and nitric oxide (NO) contained in the cell.
如第7圖(a)所示,與使用磷酸緩衝液的情況相比,使用脫脂人血清白蛋白的情況下,基於活性氧的螢光強度也減少。但是,可以得知的是,若使用白蛋白類化合物-4,則基於活性氧的螢光強度大幅度減少,不僅與添加了磷酸緩衝液的情況相比,活性氧明顯減少,而且與添加了脫脂人血清白蛋白的相比,也是活性氧減少。As shown in FIG. 7 (a), when using defatted human serum albumin, the fluorescence intensity based on active oxygen is also reduced compared to the case using a phosphate buffer. However, it can be seen that if the albumin-based compound-4 is used, the fluorescence intensity based on active oxygen is greatly reduced. Compared with the case of adding a phosphate buffer, the active oxygen is significantly reduced, Compared to defatted human serum albumin, there is also a decrease in active oxygen.
此外,如第7圖(b)所示,使用脫脂人血清白蛋白的情況與使用磷酸緩衝液的情況相比,基於一氧化氮的螢光強度增大。但是,可以得知的是,若使用白蛋白類化合物-4,則基於一氧化氮的螢光強度大幅度減少,與添加了磷酸緩衝液及脫脂人血清白蛋白的情況相比,一氧化氮大幅度減少。In addition, as shown in FIG. 7 (b), when using defatted human serum albumin, the fluorescence intensity based on nitric oxide was increased compared to the case using a phosphate buffer. However, it can be seen that if the albumin-based compound-4 is used, the fluorescence intensity based on nitric oxide is greatly reduced, and compared with the case where phosphate buffer solution and defatted human serum albumin are added, nitric oxide dramatically decrease.
第8圖係繪示用於說明黑色素產生的產生機制的機制示意圖。可以認為皮膚會如下述那樣產生黑色素。FIG. 8 is a schematic diagram illustrating a mechanism for generating a melanin production mechanism. It is thought that the skin produces melanin as described below.
首先,皮膚內的酪胺酸經由氧化酵素酪胺酸酶,轉換為度巴色素。度巴色素再由於酪胺酸酶的作用轉變為度巴燐。度巴燐的反應性高,經過體內的諸反應,最終生成穩定構造的黑色素,黑色素是導致皮膚褐變的原因。First, tyrosine in the skin is converted to duba pigment by the oxidative enzyme tyrosinase. Due to the action of tyrosinase, duba pigment is converted into duba tincture. Dopamine is highly reactive. Through various reactions in the body, melanin with a stable structure is eventually produced. Melanin is the cause of skin browning.
已知酪胺酸酶由於細胞內的活性氧(ROS)及一氧化氮(NO)而被活性化。可以認為,盡管活性氧及一氧化氮由於紫外線而增大,但只要能夠降低活性氧及一氧化氮,就能夠抑制酪胺酸酶的活性化,從而能夠抑制黑色素的產生。It is known that tyrosinase is activated by intracellular reactive oxygen species (ROS) and nitric oxide (NO). It is considered that although active oxygen and nitric oxide increase due to ultraviolet rays, as long as the active oxygen and nitric oxide can be reduced, the activation of tyrosinase can be suppressed, and the production of melanin can be suppressed.
如第7圖(a)及第7圖(b)所示,可以認為,加成了硫原子的白蛋白類化合物抑制了活性氧及一氧化氮的產生,從而降低了黑色素的產生而具有美白效果。As shown in Figures 7 (a) and 7 (b), it can be considered that the albumin compounds with added sulfur atoms inhibit the production of active oxygen and nitric oxide, thereby reducing the production of melanin and having whitening effect.
本發明所涉及的美白化粧料適於用作基礎化粧品或者美容化粧品。The whitening cosmetic material according to the present invention is suitable for use as a basic cosmetic or a cosmetic cosmetic.
第1圖係繪示第2試驗例中,細胞溶解液的波長405nm的吸光度之條形圖。 第2圖(a)、第2圖(b)及第2圖(c)分別是在第2試驗例中,培養後的B16小鼠黑色素瘤細胞的光學顯微鏡照片。 第3圖係繪示第2試驗例中,細胞溶解液中培養後的B16小鼠黑色素瘤細胞內的黑色素產生量之條形圖。 第4圖係繪示第4試驗例中,測量試樣的螢光強度之條形圖。 第5圖係繪示第4試驗例中,細胞溶解液中、培養後的B16小鼠黑色素瘤細胞內的黑色素產生量之條形圖。 第6圖係繪示第5試驗例中,乳膏劑中的細胞存活率之條形圖。 第7圖(a)及第7圖(b)分別係繪示第6試驗例中的平均螢光強度之條形圖。 第8圖係用於說明白蛋白類化合物抑制黑色素之示意圖。FIG. 1 is a bar graph showing the absorbance of the cell lysate at a wavelength of 405 nm in the second test example. Figures 2 (a), 2 (b), and 2 (c) are optical microscope photographs of B16 mouse melanoma cells after culture in the second test example, respectively. Figure 3 is a bar graph showing the amount of melanin production in B16 mouse melanoma cells cultured in cell lysate in the second test example. Figure 4 is a bar graph showing the fluorescence intensity of the test sample in the fourth test example. Figure 5 is a bar graph showing the amount of melanin produced in the melanoma cells of the B16 mouse after culturing in the cell lysate in the fourth test example. Figure 6 is a bar graph showing the cell survival rate in the cream in the fifth test example. Figures 7 (a) and 7 (b) are bar graphs showing the average fluorescence intensity in the sixth test example, respectively. Figure 8 is a schematic diagram illustrating the inhibition of melanin by albumin compounds.
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016108824 | 2016-05-31 | ||
JP2016-108824 | 2016-05-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201742617A TW201742617A (en) | 2017-12-16 |
TWI666029B true TWI666029B (en) | 2019-07-21 |
Family
ID=60477421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106117965A TWI666029B (en) | 2016-05-31 | 2017-05-31 | Use of albumin-based compound for producing skin-whitening external preparation |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2017209028A1 (en) |
TW (1) | TWI666029B (en) |
WO (1) | WO2017209028A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080318864A1 (en) * | 2007-06-25 | 2008-12-25 | Fred Hutchinson Cancer Research Center | Methods and compositions regarding polychalcogenide compositions |
CN102089319A (en) * | 2008-05-08 | 2011-06-08 | 味之素株式会社 | Protein reforming method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4178359B2 (en) * | 2001-05-01 | 2008-11-12 | 株式会社ディーエイチシー | Whitening cosmetics |
-
2017
- 2017-05-29 WO PCT/JP2017/019852 patent/WO2017209028A1/en active Application Filing
- 2017-05-29 JP JP2018520885A patent/JPWO2017209028A1/en active Pending
- 2017-05-31 TW TW106117965A patent/TWI666029B/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080318864A1 (en) * | 2007-06-25 | 2008-12-25 | Fred Hutchinson Cancer Research Center | Methods and compositions regarding polychalcogenide compositions |
CN102089319A (en) * | 2008-05-08 | 2011-06-08 | 味之素株式会社 | Protein reforming method |
Non-Patent Citations (1)
Title |
---|
Doriano cavallin et al., "Interaction of Proteins with Sulfide." Eur. J. Biochem, Vol. 14, 1970, page 169-174 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2017209028A1 (en) | 2019-04-11 |
WO2017209028A1 (en) | 2017-12-07 |
TW201742617A (en) | 2017-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3661707B2 (en) | Topical skin preparation | |
JP2000212082A (en) | Preparation for external use for skin | |
JP6043145B2 (en) | Skin external composition for body odor control | |
JPH11255639A (en) | Tyrosinase activity inhibitor and cosmetic | |
JP2005120023A (en) | Skin care preparation | |
JP5669436B2 (en) | Composition | |
JPH11255637A (en) | Tyrosinase activity inhibitor and cosmetic | |
KR102016062B1 (en) | Callus extracts from Citrus junos Siebold ex Tanaka and Pyrus pyrifolia Nakai with Whitening and Anti-wrinkle effect | |
TWI666029B (en) | Use of albumin-based compound for producing skin-whitening external preparation | |
JP2011241164A5 (en) | ||
JP6757130B2 (en) | A composition having an azulene compound, and a discoloration inhibitor and a discoloration prevention method for the azulene compound. | |
JPH02111714A (en) | Cosmetic | |
JP2003192528A (en) | Cosmetic | |
JP6957289B2 (en) | Whitening cosmetic composition | |
JP2011241166A (en) | Composition | |
JP5748996B2 (en) | Topical skin preparation | |
JP2001335472A (en) | Tyrosinase activity inhibitor and cosmetic | |
JP2011241166A5 (en) | ||
JP5154780B2 (en) | Nitric oxide production promoter and use thereof | |
JP5236335B2 (en) | Lanost-8-ene derivatives and skin external preparations containing these | |
EP2964333A1 (en) | Powdered composition for use in the preparation of whitening cosmetic compositions | |
JP4285939B2 (en) | Topical skin preparation | |
JP2786233B2 (en) | External preparation for skin | |
JP2004010505A (en) | Cosmetic | |
JPH07149622A (en) | Beautifying and whitening preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |